Clincosm LogoSign in Get a demo

VIDIS: 25- Hydroxyvitamin D Levels in Pregnancy and Effects on Pregnancy Related Disorders

Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT04637880
Collaborator
Ratiopharm GmbH (Industry)
249
Enrollment
1
Location
72
Duration (Months)
3.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Evaluation of 25- Hydroxyvitamin D levels in pregnant women in Austria and potential related disorders

Hypothesis:

Austrian pregnant women are Vitamin D deficient Present vitamin D supplementation in pregnancy is insufficient Vitamin D deficiency is associated with pregnancy related disorders like preeclampsia

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    249 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    25- Hydroxyvitamin D Levels in Pregnancy and Effects on Pregnancy Related Disorders
    Study Start Date :
    Jul 1, 2012
    Actual Primary Completion Date :
    Jul 1, 2018
    Actual Study Completion Date :
    Jul 1, 2018

    Outcome Measures

    Primary Outcome Measures

    1. 25- Hydroxyvitamin D and relation to development of preeclampsia [over course of pregnancy]

    Secondary Outcome Measures

    1. 25 Hydroxyvitamin D in newborn [once at delivery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • age> 18 years

    • informed consent

    Exclusion Criteria:

    • chronic hypertension

    • kidney disease

    • lupus erythematodes

    • diabetes mellitus

    • malabsorption syndrome

    • hyperparathyroidism

    • surgery on the thyroid gland

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Obstetrics and fetomaternal Medicine, Medical University of Vienna Vienna Austria 1090

    Sponsors and Collaborators

    • Medical University of Vienna
    • Ratiopharm GmbH

    Investigators

    • Principal Investigator: Harald Zeisler, Univ. Prof. Dr., MUV

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Julia Wild, MD, Dr. med. univ, Medical University of Vienna
    ClinicalTrials.gov Identifier:
    NCT04637880
    Other Study ID Numbers:
    • V02
    First Posted:
    Nov 20, 2020
    Last Update Posted:
    Nov 20, 2020
    Last Verified:
    Nov 1, 2020
    Additional relevant MeSH terms:
    Diabetes, Gestational
    Pre-Eclampsia
    Premature Birth
    Hypertension, Pregnancy-Induced
    Vitamin D Deficiency

    Study Results

    No Results Posted as of Nov 20, 2020